Laboratory OF Immune-Cancer cell crosstalk

What we do?

We study the soluble factors (cytokines, chemokines, metabolites) that enable the cross-communication between cancer and immune cells and how we can leverage them as a potential drug target to treat cancer.

Our Tools

We use genetically engineered mouse model (GEM) of tumor, human and mouse organoid model and human patient derived xenograft (PDXs) along with functional genomics technology, metabolomic tracing and multiplexed immune profiling.